Reaction

Pneumoperitoneum reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,806 reports · 65 co-occurring drugs

As of the last recalculation, Pneumoperitoneum appears in 1,806 FAERS reports alongside 65 co-occurring drug terms. The strongest observed disproportionality signal is ERLOTINIB (PRR 21.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Erlotinib1821.621.7
Erlotinib Hydrochloride2018.618.6
Magnesium Sulfate In Water For1715.515.5
Magnesium Sulfate Heptahydrate1715.215.2
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride4015.215.2
Magnesium Sulfate1715.115.2
Mycophenilic Acid2614.714.7
Piperacillin And Tazobactam1614.514.6
Piperacillin Sodium And Tazobactam Sodium2414.314.3
Rasagiline Mesylate1212.512.5
Norepinephrine1111.911.9
Tacrolimus Ointment 0.1%11611.411.4
Tacrolimus Extended-Release Capsules11611.411.4
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose811.311.3
Zidovudine1210.410.4
Tacrolimus12810.110.1
Mycophenolic Acid279.99.9
Ketoprofen119.79.7
Remdesivir119.69.6
Vincristine Sulfate249.69.6
Sodium Bicarbonate199.59.5
Sodium Bicarbonate Injection,199.59.5
Piperacillin Sodium,Tazobactam Sodium219.29.2
Ganciclovir89.09.1
Norepinephrine Bitartrate118.98.9
Ganciclovir Sodium88.78.8
Mycophenolate Mofetil988.78.7
Mycophenolate Mofetil Hydrochloride988.78.7
Anti-Thymocyte Globulin (Rabbit)68.68.6
Polatuzumab Vedotin78.38.3
Bevacizumab838.08.1
Rotigotine108.08.0
Regorafenib88.08.0
Brentuximab Vedotin77.97.9
Leucovorin Calcium137.97.9
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride67.87.8
Sirolimus97.77.7
Fluorouracil Cream, 0.5%497.67.6
Pegaspargase87.67.6
Fluorouracil497.57.5
Imatinib117.27.2
Sevoflurane56.97.0
Rocuronium Bromide76.96.9
Amantadine96.76.7
Pemetrexed126.56.5
Nevirapine56.46.4
Doxorubicin466.16.1
Baricitinib56.06.0
Axicabtagene Ciloleucel55.95.9
Oxaliplatin365.75.7
Carbidopa And Levodopa235.65.6
Sorafenib105.65.6
Irinotecan Hydrochloride65.45.4
Sunitinib Malate175.05.0
Lenvatinib144.95.0
Pemetrexed Disodium164.94.9
Paclitaxel (Aibumin-Bound)344.84.8
Axitinib84.74.8
Obinutuzumab64.24.2
Cetuximab114.14.1
Sevelamer Carbonate44.04.0
Atezolizumab133.93.9
Crizotinib43.63.6
Pazopanib Hydrochloride83.43.4
Trifluridine And Tipiracil33.23.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.